The Eris Lifesciences IPO will see PE firm ChrysCapital sell its entire 16.25% stake in the pharma firm while founder Amit Bakshi will pare 0.5% of his stake
The Eris Lifesciences IPO will see PE firm ChrysCapital sell its entire 16.25% stake in the pharma firm while founder Amit Bakshi will pare 0.5% of his stake
Share this Article
Recommended